IP Verse

Seqirus Uk Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Seqirus Uk Limited

Patent Number:
EP2791160
Title:
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
Applicant:
MODERNA THERAPEUTICS, INC.
Opposition Date:
Dec 1, 2022
Patent Number:
EP3134131
Title:
Nucleic Acid Vaccines
Applicant:
MODERNATX, INC.
Opposition Date:
Sep 21, 2022
Patent Number:
EP3682905
Title:
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
Applicant:
MODERNATX, INC.
Opposition Date:
Sep 1, 2022

Latest patents of Seqirus Uk Limited opposed by its competitors

Patent:
EP3489211
Grant Date:
Jul 15, 2020
Title:
Improved Methods For Preparing Squalene
Oppositions:
1
Patent:
EP2614835
Grant Date:
Aug 21, 2019
Title:
Vaccination With Multiple Clades Of H5 Influenza A Virus
Oppositions:
1
Patent:
EP3103784
Grant Date:
Feb 6, 2019
Title:
Manufacture Of An Oil-In-Water Emulsion Comprising Squalene
Oppositions:
1

Competitors of Seqirus Uk Limited

GLAXOSMITHKLINE BIOLOGICALS SA

MODERNATX, INC.

MODERNA THERAPEUTICS, INC.

Want to track Seqirus Uk Limited?

Feel free to send us a message here and we will get back to you